Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

View source ↗

Summary

This clinical trial update reports on real-world outcomes and safety of atezolizumab in routine practice. It includes patients with urothelial carcinoma, non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Urothelial Carcinoma, Non-Small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING